^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    yttrium Y 90 tabituximab barzuxetan (OTSA101-DTPA-90Y)

    i
    Associations
    News
    Trials
    Company:
    OncoTherapy
    Drug class:
    Wnt signalling pathway inhibitor
    Related drugs:
    Associations
    News
    Trials